Perceived family history risk and symptomatic diagnosis of prostate cancer: The North Carolina prostate cancer outcomes study

Cancer

Volumn 113, Issue 8, 2008, Pages 2180-2187

  Spain, Pamela ^a,b   Carpenter, William R ^a   Talcott, James A ^c   Clark, Jack A ^d,e   Young, Kyung Do ^a   Hamilton, Robert J ^f   Galanko, Joseph A ^g   Jackman, Anne ^a   Godley, Paul A ^a,g,h  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b RTI INTERNATIONAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h IL   (United States)

Author keywords

Access to healthcare; African Americans psychology; Attitude to health; Diagnosis; European continental ancestry group psychology; Prostatic neoplasms; Socioeconomic factors; Treatment

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CAUCASIAN; EXERCISE; FAMILY HISTORY; HEALTH BELIEF MODEL; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RESPONSIBILITY; SOCIOECONOMICS; STATISTICAL MODEL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PERCEPTION; PHYSICIAN-PATIENT RELATIONS; PROSTATIC NEOPLASMS; RISK; SOCIOECONOMIC FACTORS;

EID: 55749107106     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23801     Document Type: Article

References (30)

1. National Cancer Institute. Prostate cancer. Available at: http://www.cancer.gov/cancertopics/types/prostate Accessed July 2007.
2. Ries LAG, Harkins D, Krapcho M, et al. 2006. Seer Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute.
3. National Cancer Institute. Surveillance Epidemiology and End Results. Cancer of the Prostate. Available at: http://seer.cancer.gov/statfacts/html/ prost.html Accessed March 28, 2007.
4. National Cancer Institute. State Cancer Profiles. Available at: www.statecancerprofiles.cancer.gov Accessed March 28, 2007.
5. Gann PH. Risk factors for prostate cancer. Rev Urol. 2002;4(suppl 5):S3-S10.
6. Parkes C, Wald NJ, Murphy P, et al. Prospective observational study to assess value of prostate specific antigen as a screening test for prostate cancer. BMJ. 1995;311:1340-1343.
7. Nicholson PW, Harland SJ. Survival prospects after screen-detection of prostate cancer. BJU Int. 2002;90:686-693.
8. Draisma G, Boer R, Otto S, et al. Lead times and over-detection because of prostate specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 2003;95:868-878.
9. Parker C, Muston D, Melia J, Moss S, Dearnaley D. A model of the national history of screen-detected prostate cancer and the effect of radical treatment on overall survival. Br J Cancer. 2006;94:1361-1368.
10. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate incidence trends. J Natl Cancer Inst. 2002;94:981-990.
11. Desireddi NV, Roehl KA, Loeb S, et al. Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era. Adult Urol. 2007;70:950-955.
12. American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008.
13. Centers for Disease Control. Are African-American men at increased risk for prostate cancer? Available at: www.cdc.gov/cancer/prostate/publications/ aadecisionguide/index.htm#aa Accessed March 28, 2007.
14. Jacobsen PB, Lamonde LA, Honour M, et al. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology. 2004;13:80-85.
15. Bloom JR, Stewart SL, Oakley-Girvans I, et al. Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev. 2006;15:2167-2173.
16. Bratt O, Damber JE, Emanuelsson M, et al. Risk perception, screening practice, and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer. 2002;36:235-241.
17. Myers RE, Hyslop T, Jennings-Dozier K, et al. Intention to be tested for prostate cancer in African American men. Cancer Epidemiol Biomarkers Prev. 2000;9:1323-1328.
18. Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health. 2000;90:1595-1600.
19. Cormier L, Kwan L, Reid K, et al. Knowledge and beliefs among brothers and sons of men with prostate cancer. Urology. 2002;59:895-900.
20. Jones AR, Shipp M, Thompson CJ, et al. Prostate cancer knowledge and beliefs among black and white older men in rural and urban counties. J Cancer Educ. 2005;20:96-102.
21. Rosenstock IM. Why people use health services. Milbank Mem Fund Q. 1996;44:94-124.
22. Talcott JA, Spain PC, Clark JA, et al. Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer. 2007;109:1599-1606.
23. Safran DG, Kosinski M, Tarlov AR, et al. The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care. 1998;36:728-739.
24. Ahmed NU, Fort JG, Elzey JD, et al. Empowering factors in repeat mammography: insights from the story of underserved women. J Ambul Care Manage. 2004;27:348-355.
25. Fowler BA. The influence of social support relationships on mammography screening in African American women. J Natl Black Nurses Assoc. 2007;18:21-29.
26. SAS Institute Inc. SAS 9.1.3. Cary, NC: SAS Institute Inc.; 2000-2004.
27. Zhang J, Yu KF. What's the Relative Risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
28. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157:940-943.
29. Hall MA, Dugan E, Zheng B, Mishra AK. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q. 2001;79:613-639.
30. O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J. The role of trust in use of preventive services among low income African American women. Prev Med. 2004;38:777-785.